Literature DB >> 14696880

Chinese red rice-induced myopathy.

Dena James Smith1, Kenneth E Olive.   

Abstract

A middle-aged man presented with joint pain and muscle weakness that had begun 2 months before presentation. Three months before presentation, he had begun to take the herbal preparation Chinese red rice. Laboratory testing revealed a moderately elevated creatine phosphokinase level. Symptoms and laboratory abnormalities resolved with discontinuation of the Chinese red rice. Eight months later, he resumed the product and his creatine phosphokinase level rose again. Lovastatin is a naturally occurring component of Chinese red rice and was the probable cause of his myopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14696880     DOI: 10.1097/01.SMJ.0000100117.79718.DC

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  9 in total

1.  Statins and muscle adverse effects: a complementary perspective.

Authors:  Beatrice A Golomb; Sabrina Kopersk; Marcella A Evans
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

Review 2.  The role of red yeast rice for the physician.

Authors:  Ram Y Gordon; David J Becker
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

3.  Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system.

Authors:  Gabriela Mazzanti; Paola Angela Moro; Emanuel Raschi; Roberto Da Cas; Francesca Menniti-Ippolito
Journal:  Br J Clin Pharmacol       Date:  2017-01-19       Impact factor: 4.335

4.  No additional cholesterol-lowering effect observed in the combined treatment of red yeast rice and Lactobacillus casei in hyperlipidemic patients: A double-blind randomized controlled clinical trial.

Authors:  Chien-Ying Lee; Min-Chien Yu; Wu-Tsun Perng; Chun-Che Lin; Ming-Yung Lee; Ya-Lan Chang; Ya-Yun Lai; Yi-Ching Lee; Yu-Hsiang Kuan; James Cheng-Chung Wei; Hung-Che Shih
Journal:  Chin J Integr Med       Date:  2016-11-12       Impact factor: 1.978

5.  Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia.

Authors:  Matthew Klimek; Shan Wang; Adeleye Ogunkanmi
Journal:  P T       Date:  2009-06

6.  NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements.

Authors:  Dirk W Lachenmeier; Yulia B Monakhova; Thomas Kuballa; Sigrid Löbell-Behrends; Sibylle Maixner; Matthias Kohl-Himmelseher; Asja Waldner; Christian Steffen
Journal:  Chin Med       Date:  2012-03-22       Impact factor: 5.455

7.  Mediterranean Diet and Red Yeast Rice Supplementation for the Management of Hyperlipidemia in Statin-Intolerant Patients with or without Type 2 Diabetes.

Authors:  Giovanni Sartore; Sartore Giovanni; Silvia Burlina; Burlina Silvia; Eugenio Ragazzi; Ragazzi Eugenio; Stefania Ferraresso; Ferraresso Stefania; Romina Valentini; Valentini Romina; Annunziata Lapolla; Lapolla Annunziata
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-23       Impact factor: 2.629

8.  Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin.

Authors:  Chia-Hao Chen; Yow-Shieng Uang; Shang-Ta Wang; Jyh-Chin Yang; Chun-Jung Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-14       Impact factor: 2.629

9.  Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb.

Authors:  Misha F Vrolijk; Sonja van de Koppel; Florence van Hunsel
Journal:  Br J Clin Pharmacol       Date:  2020-11-18       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.